PCT-guided antibiotic therapy in ICU patients

Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis EJRC Article Review   Procalcitonin (PCT) is an acute-phase protein that has been extensively studied as a specific marker of bacterial infection. Its main proposed value is reduced use of antibiotics. PCT measurement has been recommended in the most recent edition of […]

Read More…

Impact of the Surviving Sepsis Campaign

icTV Update Ricard Ferrer Roca from the SSC Steering Committee updates on the overall impact of the campaign in Europe and beyond and describes the most important elements of the care bundles for healthcare professionals to adhere to in managing patients with sepsis. For more information on the Surviving Sepsis Campaign, visit the website. […]

Read More…

(icTV) Surviving Sepsis Campaign: Performance metrics and outcomes

Results from a 7.5-year study published in ICM In this icTV interview, Mitchell Levy updates us on the Surviving Sepsis Campaign and describes results recently published in Intensive Care Medicine. Read the article in ICM: Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. […]

Read More…

SEPSIS STUDY UPDATE

icTV interview with Mitchell Levy In this icTV interview, Mitchell Levy, Co-PI of IMPRESS, updates on this important observational study on sepsis and septic shock carried out by ESICM and SCCM under the framework of the Surviving Sepsis Campaign (SSC). For more details about IMPRESS, visit the website. To learn more about the SSC, visit our dedicated webpage  & […]

Read More…

Surviving Sepsis Campaign: The Next Phase…

Implementing the Guidelines In this icTV video from our SEPSIS SERIES, Richard Beale discusses the reasoning behind the low rates of adherence, despite the evidence that implementation of the SSC guidelines is effective in lowering severity and mortality in septic patients. He notes that a key priority for the next phase of the Surviving Sepsis […]

Read More…

SEPSIS SERIES ~ From Bench to Community

Expanding a Winning SSC Strategy  In this icTV interview for the Sepsis Series, we caught up with President Jean-Daniel Chiche in Montreux at ESICM’s conference “Sepsis From Bench to Bedside”. Chiche discusses the importance of scientific societies focusing on translational medicine and details the need for expansion of the Surviving Sepsis Campaign’s (SSC) success. JD […]

Read More…

What to do if you suspect Sepsis

SEPSIS SERIES  In this icTV video from our Sepsis Series, Rupert Pearse describes the importance of early diagnosis of sepsis in patients and provides key treatment strategies for what to do if the condition is suspected. For more information on sepsis diagnosis and treatment, please visit the Surviving Sepsis Campaign website. […]

Read More…

How to Implement SSC Guidelines in Your Hospital

Sepsis Series  In this interview from our series on sepsis, Ricard Ferrer Roca provides step-by-step organisational tips on how to implement the updated Surviving Sepsis Campaign (SSC) Guidelines in your hospital. Ricard Ferrer Roca will be presenting on behalf of the SSC at the conference Sepsis From Bench to Bedside July 4-5 in Montreux. […]

Read More…

SEPSIS SERIES: SSC affects 25% reduction in mortality rates

Future Expansion & Implementation  As part of our Sepsis Series to mark the start of the next phase of the Surviving Sepsis Campaign (SSC), ESICM President Jean-Daniel Chiche details the success and overall impact of the campaign thus far. He notes the improved mortality rates and discusses future expansion of the SSC – including […]

Read More…

SEPSIS SERIES: Antimicrobial Therapy

The 3 Key Factors  In this icTV video from our continuing Sepsis Series, Ricard Ferrer Roca outlines the main factors to consider in the use of antimicrobials in patients with sepsis. For more information and treatment guidelines, please visit the Surviving Sepsis Campaign website. […]

Read More…